Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
"When unscrupulous providers offer umbilical cord blood stem cell products and treatments that are both unapproved and unproven, they put consumers' health at risk, and multiple users of this firm's products in fact suffered adverse events." https://t.co/vfU0S7REMC
ICYMI: 1st successful federal criminal charges for stem cell clinic firm leader in modern era. It's encouraging but will FDA, FTC and/or DOJ do more about 100s of others out there? This firm Liveyon was arguably not the worst https://t.co/ZCSJIrKSOw #stemcells
The marketing of unproven stem cell treatments remains a massive policy issue. Good to see some action... Founder and Chief Executive Officer of Injectable Stem Cell Product Manufacturer Pleads Guilty to Felony Distribution of Unapproved Drug https://t.co/eLd9bZeAQT…
An Orange County man has pleaded guilty to the felony distribution of an unapproved drug intended to treat serious diseases. This case marks the first successful federal criminal charges against a leader of a stem cell clinic firm in the modern era. The founder and CEO of the injectable stem cell product manufacturer, Liveyon, was found guilty, highlighting ongoing concerns about the marketing of unproven stem cell treatments. The guilty plea underscores the risks posed by unscrupulous providers offering unapproved and unproven umbilical cord blood stem cell products, which have led to adverse events among users. The verdict against the Lung Institute further demonstrates that scammers in this field can be held accountable.